Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02949037 · ClinicalTrials.gov registry record · NA
Enhancing mHealth Technology to Activate Chronic Care Patients
A NA study, sponsored by Clemson University.
- Completed
- Registry status
- NA
- Development phase
- 229
- Enrollment target
NCT02949037: Completed NA study, sponsored by Clemson University.
NCT02949037 is a NA study that has completed, run by Clemson University. The registered enrollment target is 229 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02949037, a NA study, has completed, sponsored by Clemson University.
- COMPLETED
- Registry status
- NA
- Development phase
- 229 participants
- Enrollment target
Study Summary
Multi-site feasibility study designed to assist type-2 diabetes patients in self-care activities. The study includes Bluetooth-enabled medical devices (i.e. scales, blood pressure cuffs, glucometers, and activity monitors) for both intervention and control groups. Those in the intervention group will have the devices linked too a mobile health care environment that provides key benefits that include: device data trending, reinforcing tailored behavioral messages, and enhanced communication with the clinic.
Primary Outcome
PAM is a validated survey measure of patient activation
Interventions
- OTHER Mobile Health Care Environment (MHCE)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 229 participants |
| Start Date | 2017-07-01 |
| Est. Completion | 2019-10-04 |
| Phase | NA |
What the finished NCT02949037 record still lists
NCT02949037 is an interventional study that assigns participants to a tested intervention. The registered 229 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).
The record links to 0 conditions, and to 1 intervention - of which Mobile Health Care Environment (MHCE) is the first listed.
NCT02949037 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02949037 about?
NCT02949037 is a clinical study titled "Enhancing mHealth Technology to Activate Chronic Care Patients". Multi-site feasibility study designed to assist type-2 diabetes patients in self-care activities. The study includes Bluetooth-enabled medical devices (i.e. scales, blood pressure cuffs, glucometers, and activity monitors) for both intervention and control groups. Those in the intervention group wil...
What is the current status of trial NCT02949037?
This trial is currently completed. It is a NA study. The enrollment target is 229 participants. The study started on 2017-07-01. Estimated completion is 2019-10-04.
What interventions are being tested in trial NCT02949037?
The interventions under investigation include: Mobile Health Care Environment (MHCE) (OTHER).
Who is sponsoring clinical trial NCT02949037?
This trial is sponsored by Clemson University, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02949037's enrollment target sits among peer trials
229 468th of 2000 higher than 1,533 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02710253 · 230 participants · Phase 2
Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy
- NCT02777879 · 230 participants
Lung Microbiome and Inflammation in Early COPD
- NCT03824483 · 230 participants · Phase 2
Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)
- NCT03833622 · 230 participants · NA
Shared Decision Making to Improve Goals of Care in the ED
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI